These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles. Jarvis SK, Abbott JA, Lenart MB, Steensma A, Vancaillie TG. Aust N Z J Obstet Gynaecol; 2004 Feb; 44(1):46-50. PubMed ID: 15089868 [Abstract] [Full Text] [Related]
9. An open-label multicentric study of the tolerability and response to escitalopram treatment in Indian patients with major depressive disorder. Pinto C, Trivedi JK, Vankar GK, Sharma PS, Narasimha V. J Indian Med Assoc; 2007 Jul; 105(7):364, 366, 368 passim. PubMed ID: 18178988 [Abstract] [Full Text] [Related]
10. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use. Peniston JH, Gould E. Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907 [Abstract] [Full Text] [Related]
14. The response to sertraline in men with chronic pelvic pain syndrome. Lee RA, West RM, Wilson JD. Sex Transm Infect; 2005 Apr; 81(2):147-9. PubMed ID: 15800093 [Abstract] [Full Text] [Related]
16. Escitalopram for perimenopausal depression: an open-label pilot study. Freeman MP, Hill R, Brumbach BH. J Womens Health (Larchmt); 2006 Sep; 15(7):857-61. PubMed ID: 16999641 [Abstract] [Full Text] [Related]
17. Escitalopram in the treatment of major depressive disorder in primary-care settings: an open-label trial. Chokka P, Legault M. Depress Anxiety; 2008 Sep; 25(12):E173-81. PubMed ID: 19006260 [Abstract] [Full Text] [Related]